Jan Skvarka's Net Worth
$1.9 Million
Who is Jan Skvarka?
Jan Skvarka has an estimated net worth of $1.9 Million. This is based on reported shares across multiple companies, which include Trillium Therapeutics Inc., Monte Rosa Therapeutics, Inc., and Zentalis Pharmaceuticals, Inc..
SEC CIK
Jan Skvarka's CIK is 0001838042
Past Insider Trading and Trends
2021 was Jan Skvarka's most active year for acquiring shares with 5 total transactions. Jan Skvarka's most active month to acquire stocks was the month of May. 2021 was Jan Skvarka's most active year for disposing of shares, totalling 12 transactions. Jan Skvarka's most active month to dispose stocks was the month of April. 2021 saw Jan Skvarka paying a total of $63,217.37 for 155,500 shares, this is the most they've acquired in one year. In 2021 Jan Skvarka cashed out on 2,270,500 shares for a total of $1,577,470.14, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Trillium Therapeutics Inc. No price found
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 17
| |||
Form 4
|
—
|
0
|
$4.81 | -$1,149,138.98 |
0
|
May 11 - May 12
| |||
Form 4
|
—
|
0
|
$7.73 | -$365,113.78 |
0
|
Scheduled
|
Jan 13 - Jan 14
| ||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Monte Rosa Therapeutics, Inc. (GLUE) Snapshot price: $5.69
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Zentalis Pharmaceuticals, Inc. (ZNTL) Snapshot price: $2.96
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +86.68% | 41.58K |
—
|
—
| 89.55K |
Jun 21
| |||
Form 4
| -9.44% | -5.00K |
$25.05 | -$125,237.50 | 47.97K |
Sep 11
| |||
Form 4
| +44.70% | 16.36K |
—
|
—
| 52.97K |
Jun 16
| |||
Form 4
|
∞
| 36.61K |
—
|
—
| 36.61K |
Sep 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||